Reuters logo
BRIEF-FIT Biotech updates on issue of convertible notes and warrants
January 2, 2017 / 3:43 PM / a year ago

BRIEF-FIT Biotech updates on issue of convertible notes and warrants

Jan 2 (Reuters) - FIT Biotech Oy :

* Board of directors has decided on issue of convertible notes and warrants

* Board decided to withdraw a third tranche of 250,000 euros ($261,625) included in programme and to issue to Bracknor Investment total of 250 convertible notes and 3,387,534 warrants

Source text for Eikon:

Further company coverage: ($1 = 0.9556 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below